JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4660 PI-3065

Target: PI3K

Summary: P110δkinase inhibitor

≥22.7 mg/mL
A3010 MK-2206 dihydrochloride
21 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3015 BKM120
1 Citation

Target: PI3K

Summary: Inhibitor of pan-Class I PI3K

≥20.52 mg/mL
A3368 DMAT
2 Citation

Target: Pim|CK2|HIPK2|HIPK3

Summary: CK2 inhibitor,potent and selective

≥23.85 mg/mL
A3570 LY2090314

Target: GSK-3

Summary: Potent GSK-3 inhibitor

insoluble in H2O; ≥91 mg/mL
A3724 PI-103 Hydrochloride

Target: PI3K|mTOR|DNA-PK

Summary: DNA-PK/PI 3-kinase/mTOR inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.25 mg/mL
A8764 Rapalink-1

Target: mTOR

Summary: third-generation mTOR inhibitor

≥178.4 mg/mL
B1047 GDC-0032

Target: PI3K

Summary: PI3Kα inhibitor

≥23.05 mg/mL
B2228 PF-4708671
1 Citation

Target: p70 rsk

Summary: P70 S6K1 isoform inhibitor,cell-permeable

≥37.8 mg/mL